These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 19351405

  • 1. Concurrent chemoradiotherapy in adjuvant treatment of breast cancer.
    Ismaili N, Mellas N, Masbah O, Elmajjaoui S, Arifi S, Bekkouch I, Ahid S, Bazid Z, Tazi MA, Erraki A, El Mesbahi O, Benjaafar N, El Gueddari Bel K, Ismaili M, Afqir S, Errihani H.
    Radiat Oncol; 2009 Apr 07; 4():12. PubMed ID: 19351405
    [Abstract] [Full Text] [Related]

  • 2. Concurrent versus sequential administration of CMF chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer.
    Kim K, Chie EK, Han W, Noh DY, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW.
    Tumori; 2011 Apr 07; 97(3):280-5. PubMed ID: 21789003
    [Abstract] [Full Text] [Related]

  • 3. Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial.
    Fernando IN, Bowden SJ, Herring K, Brookes CL, Ahmed I, Marshall A, Grieve R, Churn M, Spooner D, Latief TN, Agrawal RK, Brunt AM, Stevens A, Goodman A, Canney P, Bishop J, Ritchie D, Dunn J, Poole CJ, Rea DW, SECRAB Investigators.
    Radiother Oncol; 2020 Jan 07; 142():52-61. PubMed ID: 31785830
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen.
    Isaac N, Panzarella T, Lau A, Mayers C, Kirkbride P, Tannock IF, Vallis KA.
    Cancer; 2002 Aug 15; 95(4):696-703. PubMed ID: 12209711
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.
    Francis P, Crown J, Di Leo A, Buyse M, Balil A, Andersson M, Nordenskjöld B, Lang I, Jakesz R, Vorobiof D, Gutiérrez J, van Hazel G, Dolci S, Jamin S, Bendahmane B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, Piccart-Gebhart M, BIG 02-98 Collaborative Group.
    J Natl Cancer Inst; 2008 Jan 16; 100(2):121-33. PubMed ID: 18182617
    [Abstract] [Full Text] [Related]

  • 9. Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients. a prospective, comparative, non-randomised study.
    Fiets WE, van Helvoirt RP, Nortier JW, van der Tweel I, Struikmans H.
    Eur J Cancer; 2003 May 16; 39(8):1081-8. PubMed ID: 12736107
    [Abstract] [Full Text] [Related]

  • 10. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
    Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K.
    N Engl J Med; 1997 Oct 02; 337(14):949-55. PubMed ID: 9395428
    [Abstract] [Full Text] [Related]

  • 11. Concurrent sequencing of full-dose CMF chemotherapy and radiation therapy in early breast cancer has no effect on treatment delivery.
    Faul C, Brufsky A, Gerszten K, Flickinger J, Kunschner A, Jacob H, Vogel V.
    Eur J Cancer; 2003 Apr 02; 39(6):763-8. PubMed ID: 12651201
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma.
    Livi L, Saieva C, Borghesi S, Paoletti L, Meattini I, Rampini A, Petrucci A, Scoccianti S, Paiar F, Cataliotti L, Leonulli BG, Bianchi S, Biti GP.
    Int J Radiat Oncol Biol Phys; 2008 Jul 01; 71(3):705-9. PubMed ID: 18191333
    [Abstract] [Full Text] [Related]

  • 17. Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer.
    Valagussa P, Moliterni A, Terenziani M, Zambetti M, Bonadonna G.
    Ann Oncol; 1994 Nov 01; 5(9):803-8. PubMed ID: 7848882
    [Abstract] [Full Text] [Related]

  • 18. Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group.
    Wallgren A, Bernier J, Gelber RD, Goldhirsch A, Roncadin M, Joseph D, Castiglione-Gertsch M.
    Int J Radiat Oncol Biol Phys; 1996 Jul 01; 35(4):649-59. PubMed ID: 8690630
    [Abstract] [Full Text] [Related]

  • 19. Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients.
    Bernard-Marty C, Mano M, Paesmans M, Accettura C, Munoz-Bermeo R, Richard T, Kleiber K, Cardoso F, Lobelle JP, Larsimont D, Piccart MJ, Di Leo A.
    Ann Oncol; 2003 May 01; 14(5):693-8. PubMed ID: 12702521
    [Abstract] [Full Text] [Related]

  • 20. Adjuvant sequential chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil (ACMF) with concurrent radiotherapy in resectable advanced breast cancer.
    Hsieh CI, Liu MC, Cheng SH, Liu TW, Chen CM, Chen CM, Tsou MH, Huang AT.
    Am J Clin Oncol; 2000 Apr 01; 23(2):122-7. PubMed ID: 10776970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.